Business Wire

CO-WESTERN-UNION-COMPANY

30.4.2021 23:10:10 CEST | Business Wire | Press release

Share
Western Union Supports India COVID Relief

The Western Union Company (NYSE: WU), a global leader in cross-border, cross-currency money movement and payments, and the Western Union Foundation today announced a package of relief efforts for India aimed at combating its latest, devastating phase in the COVID-19 pandemic, and kicked off a fundraising appeal with Western Union employees worldwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210430005585/en/

In collaboration with United Way India (UWI), the Western Union Foundation will fund medical respiratory support machines for hospitals and at-home care kits for families, expected to benefit up to 5,000 households in the Maharashtra region immediately. Beginning May 4th , Western Union will also waive transfer fees*—for two weeks for digital channels, and four weeks for retail channels—for monies sent by family and friends from select countries directly into Indian bank accounts.

“We stand in solidarity with the people of India as they confront this latest phase of the COVID-19 pandemic. Our thoughts and prayers are with our customers, our agents, our employees and their families,” said Sohini Rajola, Head of Regional Network, Middle East and APAC.

“The people of India, my home nation, are showing remarkable courage and resilience. We are comforted that the financial support of the Western Union Foundation and our zero-fee action will contribute to much-needed medical relief and facilitate additional financial flows into the country, supporting people’s everyday needs, including medicine and health care,” she said.

“A core mission of the Western Union Foundation is the support of vulnerable people in times of extreme need,” said Executive Director Elizabeth Roscoe. “Working with United Way India, we are hopeful that our resources will help the people of the Maharashtra region as they grapple with this crisis.

“We also want to extend our deepest gratitude to local emergency and health care workers, whose efforts in the face of unimaginable difficulty are an ongoing inspiration to people everywhere,” Roscoe said.

Western Union Foundation & United Way India

UWI, in conjunction with large government hospitals, will manage the distribution of respiratory support machines such as non-invasive ventilators and oxygen generators, which are critically required at hospitals—particularly to help support patients who are in the moderately severe category from getting worse.

UWI will also deliver at-home care kits suitable to treat non-critical COVID patients outside the hospital by equipping them with COVID monitoring techniques, oximeters to monitor blood oxygen levels, and thermometers. The at-home care kits enable families to monitor their symptoms without a hospital trip that risks exposure and further burdening already overwhelmed health care facilities. This program will primarily serve underprivileged patients across the hardest-hit, most remote, and lowest-income communities in the region.

The Western Union Foundation has committed $200,000 to the United Way India for this effort (NOTE: assuming all the funds will be given to UWI directly). Further, all funds raised by the Foundation’s Western Union employee appeal will be granted to UWI, with the goal of raising an additional $50,000.

Western Union Zero-transfer fee to Indian Bank Accounts

Commencing May 4th , 2021, Western Union will waive transfer fees* to Indian bank accounts, for two weeks for digital channels, through May 18th ; and four weeks for retail channels, through June 4th . To avail themselves of the offer, customers must send money directly into Indian bank accounts via westernunion.com and the Western union mobile app from Canada, Europe & CIS and the U.S.; and from retail agent locations across Australia, Canada, Europe & CIS, New Zealand and the U.S.**

About Western Union

The Western Union Company (NYSE: WU) is a global leader in cross-border, cross-currency money movement and payments. Western Union’s platform provides seamless cross-border flows and its leading global financial network bridges more than 200 countries and territories and over 130 currencies. We connect businesses, financial institutions, governments, and consumers through one of the world’s widest reaching networks, accessing billions of bank accounts, millions of digital wallets, and cards, and over half a million retail locations. Western Union connects the world to bring boundless possibilities within reach. For more information, visit www.westernunion.com .

About the Western Union Foundation

The Western Union Foundation believes that education is the surest pathway to economic opportunity. After 20 years of impact, we continue to deliver on our mission with Opportunity Beyond Borders, focused on empowering forcibly displaced and marginalized youth with the training and education needed to succeed in today’s technology-driven global economy. The Foundation also provides funding for humanitarian efforts for communities in crisis and disaster, one key reason for forced migration. To date, we have funded more than $131 million for projects and scholarships. The Western Union Foundation is a separate, tax-exempt 501(c)(3) charitable corporation and receives support from The Western Union Company, its employees, agents, and business partners. Contributions to the Foundation are tax-deductible for U.S. income tax purposes. To learn more, visit wu.com/foundation or follow us on Twitter @TheWUFoundation.

*Western Union also makes money from currency exchange. When choosing a money transmitter, carefully compare both transfer fees and exchange rates. Fees, foreign exchange rates, and taxes may vary by brand, channel, and location-based on several factors. Fees and rates subject to change without notice.

** Consumers in the U.S. and Canada were previously offered zero-transfer fee transactions into India when sending digitally for Account Payout.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye